Axcess News – Lifestyle

Author: Tevogen Bio Inc

Tevogen Names Leadership Team to Execute Diversified Growth Strategy

March 9, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi

March 7, 2026
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

March 7, 2026
Tevogen Announces Reverse Stock Split

March 7, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

March 6, 2026
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus

March 6, 2026